Account
Articles
26.01.2021
Improving access to innovative medicine in the UK

Following Brexit, the Medicines and Healthcare Regularoty Agency (MHRA) has become the UK's sole bod...

Read more
Articles
04.12.2020
What are the 5 Pricing and Market Access trends th...

Our experts predict the 5 trends they think will dominate the European pricing and market access lan...

Read more
Articles
28.10.2020
EMA regulatory decisions after BREXIT

The UK will continue to adopt decisions taken by the European Commission on the approval of new mark...

Read more
Articles
09.09.2020
Early access to medicines in the UK

This newsletter will discuss the early access processes operating within the UK and discuss the adva...

Read more
Insider Insights
09.06.2020
Innovation passport awarded to hypertension treatm

The passport is the entry point to the Innovative Licensing and Access Pathway (ILAP) which aims to ...

Read more
Newer

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch